Fair Value Disclosures (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Assets and Liabilities Measured at Fair Value on Recurring Basis |
Assets and liabilities measured at fair value on a recurring basis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 (in millions) |
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Investments Measured at NAV(1) |
|
|
Other(2) |
|
|
June 30, 2026 |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading securities |
$ |
— |
|
|
$ |
3,332 |
|
|
$ |
46 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,378 |
|
Held-to-maturity investments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
487 |
|
|
|
487 |
|
Total debt securities |
|
— |
|
|
|
3,332 |
|
|
|
46 |
|
|
|
— |
|
|
|
487 |
|
|
|
3,865 |
|
Equity securities at FVTNI: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities/mutual funds |
|
2,872 |
|
|
|
— |
|
|
|
24 |
|
|
|
— |
|
|
|
— |
|
|
|
2,896 |
|
Equity method: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity, fixed income, and multi-asset mutual funds |
|
276 |
|
|
|
159 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
435 |
|
Hedge funds/funds of hedge funds/other |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
428 |
|
|
|
— |
|
|
|
428 |
|
Private equity funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
543 |
|
|
|
— |
|
|
|
543 |
|
Real assets funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
598 |
|
|
|
— |
|
|
|
598 |
|
Investments related to deferred cash compensation plans |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
446 |
|
|
|
— |
|
|
|
446 |
|
Total equity method |
|
276 |
|
|
|
159 |
|
|
|
— |
|
|
|
2,015 |
|
|
|
— |
|
|
|
2,450 |
|
CLOs held at fair value |
|
— |
|
|
|
482 |
|
|
|
56 |
|
|
|
— |
|
|
|
— |
|
|
|
538 |
|
Federal Reserve Bank stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
88 |
|
|
|
88 |
|
Carried interest |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,594 |
|
|
|
3,594 |
|
Other investments |
|
458 |
|
|
|
— |
|
|
|
— |
|
|
|
1,133 |
|
|
|
122 |
|
|
|
1,713 |
|
Total investments |
|
3,606 |
|
|
|
3,973 |
|
|
|
126 |
|
|
|
3,148 |
|
|
|
4,291 |
|
|
|
15,144 |
|
Other assets(3) |
|
98 |
|
|
|
5 |
|
|
|
149 |
|
|
|
— |
|
|
|
— |
|
|
|
252 |
|
Separate account assets |
|
43,255 |
|
|
|
21,389 |
|
|
|
— |
|
|
|
— |
|
|
|
623 |
|
|
|
65,267 |
|
Separate account collateral held under securities lending agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
3,478 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,478 |
|
Debt securities |
|
— |
|
|
|
2,791 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,791 |
|
Total separate account collateral held under securities lending agreements |
|
3,478 |
|
|
|
2,791 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
6,269 |
|
Total |
$ |
50,437 |
|
|
$ |
28,158 |
|
|
$ |
275 |
|
|
$ |
3,148 |
|
|
$ |
4,914 |
|
|
$ |
86,932 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account collateral liabilities under securities lending agreements |
$ |
3,478 |
|
|
$ |
2,791 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,269 |
|
Contingent consideration liabilities |
|
— |
|
|
|
— |
|
|
|
7,875 |
|
|
|
— |
|
|
|
— |
|
|
|
7,875 |
|
Other liabilities(4) |
|
— |
|
|
|
134 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
134 |
|
Total |
$ |
3,478 |
|
|
$ |
2,925 |
|
|
$ |
7,875 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
14,278 |
|
(1)Amounts are comprised of certain investments measured at fair value using NAV (or its equivalent) as a practical expedient. (2)Amounts are comprised of investments held at amortized cost and cost, adjusted for observable price changes, and carried interest. (3)Level 1 amount primarily includes a minority investment in a publicly traded company. Level 3 amount includes corporate minority private debt investments with changes in fair value recorded in AOCI, net of tax. (4)Level 2 amount includes fair value of derivatives (See Note 9, Derivatives and Hedging, for more information) and other liabilities held by a CIP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 (in millions) |
Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
Significant Other Observable Inputs (Level 2) |
|
|
Significant Unobservable Inputs (Level 3) |
|
|
Investments Measured at NAV(1) |
|
|
Other(2) |
|
|
December 31, 2025 |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading securities |
$ |
— |
|
|
$ |
2,782 |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,789 |
|
Held-to-maturity investments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
507 |
|
|
|
507 |
|
Total debt securities |
|
— |
|
|
|
2,782 |
|
|
|
7 |
|
|
|
— |
|
|
|
507 |
|
|
|
3,296 |
|
Equity securities at FVTNI: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities/mutual funds |
|
2,146 |
|
|
|
— |
|
|
|
136 |
|
|
|
— |
|
|
|
— |
|
|
|
2,282 |
|
Equity method: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity, fixed income, and multi-asset mutual funds |
|
205 |
|
|
|
148 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
353 |
|
Hedge funds/funds of hedge funds/other |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
446 |
|
|
|
— |
|
|
|
446 |
|
Private equity funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
510 |
|
|
|
— |
|
|
|
510 |
|
Real assets funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
524 |
|
|
|
— |
|
|
|
524 |
|
Investments related to deferred cash compensation plans |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
300 |
|
|
|
— |
|
|
|
300 |
|
Total equity method |
|
205 |
|
|
|
148 |
|
|
|
— |
|
|
|
1,780 |
|
|
|
— |
|
|
|
2,133 |
|
CLOs held at fair value |
|
— |
|
|
|
495 |
|
|
|
73 |
|
|
|
— |
|
|
|
— |
|
|
|
568 |
|
Federal Reserve Bank stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
87 |
|
|
|
87 |
|
Carried interest |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,710 |
|
|
|
3,710 |
|
Other investments |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,078 |
|
|
|
117 |
|
|
|
1,195 |
|
Total investments |
|
2,351 |
|
|
|
3,425 |
|
|
|
216 |
|
|
|
2,858 |
|
|
|
4,421 |
|
|
|
13,271 |
|
Other assets(3) |
|
113 |
|
|
|
10 |
|
|
|
151 |
|
|
|
— |
|
|
|
— |
|
|
|
274 |
|
Separate account assets |
|
38,688 |
|
|
|
20,895 |
|
|
|
— |
|
|
|
— |
|
|
|
515 |
|
|
|
60,098 |
|
Separate account collateral held under securities lending agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
4,194 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,194 |
|
Debt securities |
|
— |
|
|
|
3,728 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,728 |
|
Total separate account collateral held under securities lending agreements |
|
4,194 |
|
|
|
3,728 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
7,922 |
|
Total |
$ |
45,346 |
|
|
$ |
28,058 |
|
|
$ |
367 |
|
|
$ |
2,858 |
|
|
$ |
4,936 |
|
|
$ |
81,565 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account collateral liabilities under securities lending agreements |
$ |
4,194 |
|
|
$ |
3,728 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,922 |
|
Contingent consideration liabilities |
|
— |
|
|
|
— |
|
|
|
8,429 |
|
|
|
— |
|
|
|
— |
|
|
|
8,429 |
|
Other liabilities(4) |
|
— |
|
|
|
13 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13 |
|
Total |
$ |
4,194 |
|
|
$ |
3,741 |
|
|
$ |
8,429 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
16,364 |
|
(1)Amounts are comprised of certain investments measured at fair value using NAV (or its equivalent) as a practical expedient. (2)Amounts are comprised of investments held at amortized cost and cost, adjusted for observable price changes, and carried interest. (3)Level 1 amount includes a minority investment in a publicly traded company. Level 3 amount includes corporate minority private debt investments with changes in fair value recorded in AOCI, net of tax. (4)Level 2 amount primarily includes fair value of derivatives (See Note 9, Derivatives and Hedging, for more information).
|
| Changes in Level 3 Assets and Liabilities Measured at Fair Value on Recurring Basis |
Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Three Months Ended June 30, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
March 31, 2026 |
|
|
Realized and Unrealized Gains (Losses) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2026 |
|
|
Total Net Unrealized Gains (Losses) Included in Earnings(1) |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading debt securities |
|
$ |
35 |
|
|
$ |
— |
|
|
$ |
30 |
|
|
$ |
(26 |
) |
|
$ |
— |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
46 |
|
|
$ |
— |
|
Equity securities/mutual funds |
|
|
136 |
|
|
|
4 |
|
|
|
6 |
|
|
|
(136 |
) |
|
|
— |
|
|
|
14 |
|
|
|
— |
|
|
|
24 |
|
|
|
4 |
|
CLOs held at fair value |
|
|
57 |
|
|
|
5 |
|
|
|
3 |
|
|
|
(6 |
) |
|
|
— |
|
|
|
2 |
|
|
|
(5 |
) |
|
|
56 |
|
|
|
5 |
|
Total investments |
|
|
228 |
|
|
|
9 |
|
|
|
39 |
|
|
|
(168 |
) |
|
|
— |
|
|
|
23 |
|
|
|
(5 |
) |
|
|
126 |
|
|
|
9 |
|
Other assets |
|
|
149 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
149 |
|
|
|
— |
|
Total assets |
|
$ |
377 |
|
|
$ |
9 |
|
|
$ |
39 |
|
|
$ |
(168 |
) |
|
$ |
— |
|
|
$ |
23 |
|
|
$ |
(5 |
) |
|
$ |
275 |
|
|
$ |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
March 31, 2026 |
|
|
Realized and Unrealized (Gains) Losses(2) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2026 |
|
|
Total Net Unrealized (Gains) Losses Included in Earnings(2)(3) |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration liabilities |
|
$ |
7,865 |
|
|
$ |
10 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,875 |
|
|
$ |
10 |
|
(1)Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date. (2)Amount includes changes in fair value of contingent consideration recorded within expense on the condensed consolidated statements of income. Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Six Months Ended June 30, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
December 31, 2025 |
|
|
Realized and Unrealized Gains (Losses) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2026 |
|
|
Total Net Unrealized Gains (Losses) Included in Earnings(2) |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading debt securities |
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
58 |
|
|
$ |
(26 |
) |
|
$ |
— |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
46 |
|
|
$ |
— |
|
Equity securities/mutual funds |
|
|
136 |
|
|
|
4 |
|
|
|
6 |
|
|
|
(136 |
) |
|
|
— |
|
|
|
14 |
|
|
|
— |
|
|
|
24 |
|
|
|
4 |
|
CLOs held at fair value |
|
|
73 |
|
|
|
(2 |
) |
|
|
3 |
|
|
|
(15 |
) |
|
|
— |
|
|
|
2 |
|
|
|
(5 |
) |
|
|
56 |
|
|
|
(2 |
) |
Total investments |
|
|
216 |
|
|
|
2 |
|
|
|
67 |
|
|
|
(177 |
) |
|
|
— |
|
|
|
23 |
|
|
|
(5 |
) |
|
|
126 |
|
|
|
2 |
|
Other assets |
|
|
151 |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
149 |
|
|
|
(2 |
) |
Total assets |
|
$ |
367 |
|
|
$ |
— |
|
|
$ |
67 |
|
|
$ |
(177 |
) |
|
$ |
— |
|
|
$ |
23 |
|
|
$ |
(5 |
) |
|
$ |
275 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
December 31, 2025 |
|
|
Realized and Unrealized (Gains) Losses(3) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2026 |
|
|
Total Net Unrealized (Gains) Losses Included in Earnings(2)(3) |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration liabilities |
|
$ |
8,429 |
|
|
$ |
(541 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(13 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,875 |
|
|
$ |
(541 |
) |
(1)Issuances and other settlements amounts include a contingent liability payment related to a previous acquisition. (2)Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date. (3)Amount includes changes in fair value of contingent consideration recorded within expense on the condensed consolidated statements of income. Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Three Months Ended June 30, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
March 31, 2025 |
|
|
Realized and Unrealized Gains (Losses) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2025 |
|
|
Total Net Unrealized Gains (Losses) Included in Earnings(2) |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading debt securities |
|
$ |
79 |
|
|
$ |
(3 |
) |
|
$ |
1 |
|
|
$ |
(1 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(1 |
) |
|
$ |
75 |
|
|
$ |
(3 |
) |
Loans |
|
|
107 |
|
|
|
2 |
|
|
|
4 |
|
|
|
(18 |
) |
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
96 |
|
|
|
2 |
|
Total investments |
|
|
186 |
|
|
|
(1 |
) |
|
|
5 |
|
|
|
(19 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
171 |
|
|
|
(1 |
) |
Other assets |
|
|
152 |
|
|
|
12 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
164 |
|
|
|
12 |
|
Total assets |
|
$ |
338 |
|
|
$ |
11 |
|
|
$ |
5 |
|
|
$ |
(19 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
335 |
|
|
$ |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
March 31, 2025 |
|
|
Realized and Unrealized (Gains) Losses |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2025 |
|
|
Total Net Unrealized (Gains) Losses Included in Earnings(2) |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration liabilities |
|
$ |
4,390 |
|
|
$ |
82 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,472 |
|
|
$ |
82 |
|
Other liabilities |
|
|
102 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5 |
) |
|
|
— |
|
|
|
— |
|
|
|
97 |
|
|
|
— |
|
Total liabilities |
|
$ |
4,492 |
|
|
$ |
82 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(5 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,569 |
|
|
$ |
82 |
|
(1)Issuances and other settlements amount includes repayments of borrowings of a consolidated CLO. (2)Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date. Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Six Months Ended June 30, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
December 31, 2024 |
|
|
Realized and Unrealized Gains (Losses) |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2025 |
|
|
Total Net Unrealized Gains (Losses) Included in Earnings(2) |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading debt securities |
|
$ |
79 |
|
|
$ |
(5 |
) |
|
$ |
5 |
|
|
$ |
(3 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(1 |
) |
|
$ |
75 |
|
|
$ |
(5 |
) |
Loans |
|
|
135 |
|
|
|
(9 |
) |
|
|
15 |
|
|
|
(46 |
) |
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
96 |
|
|
|
(9 |
) |
Total investments |
|
|
214 |
|
|
|
(14 |
) |
|
|
20 |
|
|
|
(49 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
171 |
|
|
|
(14 |
) |
Other assets |
|
|
149 |
|
|
|
15 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
164 |
|
|
|
15 |
|
Total assets |
|
$ |
363 |
|
|
$ |
1 |
|
|
$ |
20 |
|
|
$ |
(49 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
335 |
|
|
$ |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
December 31, 2024 |
|
|
Realized and Unrealized (Gains) Losses |
|
|
Purchases |
|
|
Sales and Maturities |
|
|
Issuances and Other Settlements(1) |
|
|
Transfers into Level 3 |
|
|
Transfers out of Level 3 |
|
|
June 30, 2025 |
|
|
Total Net Unrealized (Gains) Losses Included in Earnings(2) |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration liabilities |
|
$ |
4,302 |
|
|
$ |
181 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(11 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,472 |
|
|
$ |
181 |
|
Other liabilities |
|
|
129 |
|
|
|
(3 |
) |
|
|
— |
|
|
|
— |
|
|
|
(29 |
) |
|
|
— |
|
|
|
— |
|
|
|
97 |
|
|
|
(3 |
) |
Total liabilities |
|
$ |
4,431 |
|
|
$ |
178 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(40 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,569 |
|
|
$ |
178 |
|
(1)Issuances and other settlements amounts include a contingent liability payment related to a previous acquisition and repayments of borrowings of a consolidated CLO. (2)Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date.
|
| Fair Value of Financial Assets and Financial Liabilities |
Disclosures of Fair Value for Financial Instruments Not Held at Fair Value. At June 30, 2026 and December 31, 2025, the fair value of the Company’s financial instruments not held at fair value are categorized in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
|
|
|
(in millions) |
Carrying Amount |
|
|
Estimated Fair Value |
|
|
Carrying Amount |
|
|
Estimated Fair Value |
|
|
Fair Value Hierarchy |
|
Financial assets(1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
10,492 |
|
|
$ |
10,492 |
|
|
$ |
11,468 |
|
|
$ |
11,468 |
|
|
Level 1 |
(2)(3) |
Other assets |
$ |
147 |
|
|
$ |
147 |
|
|
$ |
103 |
|
|
$ |
103 |
|
|
Level 1 |
(2)(4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term borrowings |
$ |
12,744 |
|
|
$ |
12,343 |
|
|
$ |
12,768 |
|
|
$ |
12,546 |
|
|
Level 2 |
(5) |
Other liabilities |
$ |
428 |
|
|
$ |
428 |
|
|
$ |
302 |
|
|
$ |
302 |
|
|
Level 2 |
(6) |
(1)See Note 5, Investments, for further information on investments not held at fair value. (2)Cash and cash equivalents, other than money market funds, are carried at either cost or amortized cost, which approximates fair value due to their short-term maturities. (3)At June 30, 2026 and December 31, 2025, approximately $3.9 billion and $5.3 billion, respectively, of money market funds were recorded within cash and cash equivalents on the condensed consolidated statements of financial condition. Money market funds are valued based on quoted market prices, or $1.00 per share, which generally is the NAV of the fund. (4)At June 30, 2026 and December 31, 2025, other assets included cash collateral of approximately $125 million and $81 million, respectively. See Note 9, Derivatives and Hedging for further information on derivatives held by the Company. In addition, other assets included $22 million of restricted cash at both June 30, 2026 and December 31, 2025. (5)Long-term borrowings are recorded at amortized cost, net of debt issuance costs. The fair value of the long-term borrowings, including the current portion of long-term borrowings, is determined using market prices and the EUR/USD foreign exchange rate at the end of June 2026 and December 2025, respectively. See Note 14, Borrowings, for the fair value of each of the Company’s long-term borrowings. (6)Other liabilities primarily include repurchase agreements related to CIPs as well as CLO financing arrangements to finance portions of investments in certain CLOs managed by the Company. Repurchase agreements were recorded at amortized cost, which approximates fair value, with maturity dates primarily ranging from 2034 to 2039.
|
| Investments in Certain Entities that Calculate Net Asset Value per Share |
The following tables list information regarding all investments that use a fair value measurement to account for both their financial assets and financial liabilities in their calculation of a NAV per share (or equivalent).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
Ref |
|
Fair Value |
|
|
Total Unfunded Commitments |
|
|
Redemption Frequency |
|
Redemption Notice Period |
Equity method(1): |
|
|
|
|
|
|
|
|
|
|
|
|
Hedge funds/funds of hedge funds/other |
|
(a) |
|
$ |
428 |
|
|
$ |
164 |
|
|
Daily/Monthly (2%) Quarterly (13%) N/R (85%) |
|
1 – 90 days |
Private equity funds |
|
(b) |
|
|
543 |
|
|
|
203 |
|
|
N/R |
|
N/R |
Real assets funds |
|
(c) |
|
|
598 |
|
|
|
1,950 |
|
|
Quarterly (6%) N/R (94%) |
|
60 days |
Investments related to deferred cash compensation plans |
|
(d) |
|
|
446 |
|
|
|
— |
|
|
Monthly |
|
1 – 90 days |
Other investments: |
|
|
|
|
|
|
|
|
|
|
|
|
Private credit funds |
|
(a) |
|
|
145 |
|
|
|
— |
|
|
Quarterly |
|
30 days |
Consolidated sponsored investment products: |
|
|
|
|
|
|
|
|
|
|
|
|
Real assets funds |
|
(c) |
|
|
327 |
|
|
|
24 |
|
|
N/R |
|
N/R |
Private equity funds |
|
(e) |
|
|
317 |
|
|
|
28 |
|
|
N/R |
|
N/R |
Hedge funds/other |
|
(a) |
|
|
344 |
|
|
|
37 |
|
|
Quarterly (88%) N/R (12%) |
|
60 – 90 days |
Total |
|
|
|
$ |
3,148 |
|
|
$ |
2,406 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
Ref |
|
Fair Value |
|
|
Total Unfunded Commitments |
|
|
Redemption Frequency |
|
Redemption Notice Period |
Equity method(1): |
|
|
|
|
|
|
|
|
|
|
|
|
Hedge funds/funds of hedge funds/other |
|
(a) |
|
$ |
446 |
|
|
$ |
150 |
|
|
Quarterly (12%) N/R (88%) |
|
1 – 90 days |
Private equity funds |
|
(b) |
|
|
510 |
|
|
|
225 |
|
|
N/R |
|
N/R |
Real assets funds |
|
(c) |
|
|
524 |
|
|
|
1,870 |
|
|
Quarterly (7%) N/R (93%) |
|
60 days |
Investments related to deferred cash compensation plans |
|
(d) |
|
|
300 |
|
|
|
— |
|
|
Monthly |
|
1 – 90 days |
Other investments: |
|
|
|
|
|
|
|
|
|
|
|
|
Private credit funds |
|
(a) |
|
|
140 |
|
|
|
— |
|
|
Quarterly |
|
30 days |
Consolidated sponsored investment products: |
|
|
|
|
|
|
|
|
|
|
|
|
Real assets funds |
|
(c) |
|
|
372 |
|
|
|
29 |
|
|
N/R |
|
N/R |
Private equity funds |
|
(e) |
|
|
181 |
|
|
|
34 |
|
|
N/R |
|
N/R |
Hedge funds/other |
|
(a) |
|
|
385 |
|
|
|
48 |
|
|
Quarterly (89%) N/R (11%) |
|
60 – 90 days |
Total |
|
|
|
$ |
2,858 |
|
|
$ |
2,356 |
|
|
|
|
|
N/R – Not Redeemable (1)Comprised of equity method investments, which include investment companies that account for their financial assets and most financial liabilities under fair value measures; therefore, the Company’s investment in such equity method investees approximates fair value. (a)This category includes hedge funds, funds of hedge funds, and other funds that invest primarily in equities, fixed income securities, private credit, opportunistic and mortgage instruments and other third-party hedge funds. The fair values of the investments have been estimated using the NAV of the Company’s ownership interest in partners’ capital. The liquidation period for the investments in the funds that are not subject to redemption is unknown at both June 30, 2026 and December 31, 2025. (b)This category includes private equity funds that initially invest in nonmarketable securities of private companies, which ultimately may become public in the future. The fair values of these investments have been estimated using capital accounts representing the Company’s ownership interest in the funds and may also include other performance inputs. The Company’s investment in each fund is not subject to redemption and is normally returned through distributions as a result of the liquidation of the underlying assets of the private equity funds. The liquidation period for the investments in these funds is unknown at both June 30, 2026 and December 31, 2025. (c)This category includes several real assets funds that invest directly and indirectly in real estate or infrastructure. The fair values of the investments have been estimated using capital accounts representing the Company’s ownership interest in the funds. The Company’s investments that are not subject to redemption or are not currently redeemable are normally returned through distributions and realizations of the underlying assets of the funds. The liquidation period for the investments in the funds that are not subject to redemptions is unknown at both June 30, 2026 and December 31, 2025. (d)This category includes hedge funds and funds of hedge funds that invest primarily in equities, fixed income securities, mortgage instruments and other third-party hedge funds. The fair values of the investments have been estimated using the NAV of the Company's ownership interest in partners' capital. The investments in hedge funds will be redeemed upon settlement of certain deferred cash compensation liabilities. (e)This category includes the underlying third-party private equity funds within consolidated BlackRock sponsored private equity funds of funds. These investments are not subject to redemption or are not currently redeemable; however, for certain funds, the Company may sell or transfer its interest, which may need approval by the general partner of the underlying funds. Due to the nature of the investments in this category, the Company reduces its investment by distributions that are received through the realization of the underlying assets of the funds. The liquidation period for the underlying assets of these funds is unknown.
|